Tango Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:TNGX) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 33.39 M36.65 M41.7 M36.52 M30.95 M 145.81 M Cash from investing activities 32.57 M52.06 M30.6 M16.78 M47.48 M 146.91 M Cash from financing activities 2.4 M969 K2 000581 K2.54 M 4.09 M Free cash flow 33.27 M36.52 M41.65 M35.9 M30.8 M 144.87 M

Notizie

Stifel conferma rating Buy su Tango Therapeutics

Stifel reiterates Tango Therapeutics stock rating at Buy

RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View

Le azioni di Tango Therapeutics raggiungono il massimo a 52 settimane a 13,5 USD

Tango Therapeutics stock hits 52-week high at 13.5 USD

Mizuho avvia la copertura su Tango Therapeutics con rating outperform

Mizuho initiates Tango Therapeutics stock with outperform rating

Le azioni di Tango Therapeutics raggiungono il massimo di 52 settimane a $13,47

Tango Therapeutics stock hits 52-week high at $13.47

Il CFO di Tango Therapeutics vende azioni TNGX per 126.530 dollari

Tango Therapeutics CFO sells $126,530 in TNGX stock

Weber Barbara, direttrice di Tango Therapeutics, vende azioni TNGX per 374.000$